Hematology/Oncology

Top Story

Mount Sinai thoracic surgeon receives award

Mount Sinai thoracic surgeon receives award
May 25, 2019

FDA approves Piqray, first PI3K inhibitor for advanced breast cancer

May 24, 2019
The FDA on Friday approved alpelisib, the first PI3K inhibitor to treat postmenopausal women and men with hormone receptor-positive, HER2-negative, PIK3CA-mutated…
FDA News

FDA approves Jakafi for acute graft-versus-host disease

May 24, 2019
The FDA approved ruxolitinib for the treatment of steroid-refractory acute graft-versus-host disease among adults and children aged 12 years and older. Ruxolitinib…
Meeting NewsVideo

VIDEO: Stool-based colon cancer tests may be effective between scheduled colonoscopies

May 24, 2019
SAN DIEGO — In this exclusive video from Digestive Disease Week, John B. Kisiel, MD, a gastroenterologist at the Mayo Clinic, discusses the results of two studies…
Meeting NewsVideo

VIDEO: Novel DNA markers accurately detect pancreatic cancer across all stages

May 24, 2019
SAN DIEGO — In this video from Digestive Disease Week, Shounak Majumder, MD, a gastroenterologist at the Mayo Clinic, discusses the results of a study that…
More Headlines »
CME

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from Merck & Co., Inc.

The integration of immune checkpoint inhibitors into treatment algorithms for patients with bladder cancer who have…
More »
Video
Meeting News

VIDEO: Durvalumab represents ‘major step forward’ in lung cancer

April 16, 2019
More »
Resource Centers
HemOnc Today New York

HemOnc Today New York

CME CNE CPE

Advances in the Management of Toxicities Associated with Stem Cell Transplant

This activity is supported by an educational grant from Cumberland Pharmaceuticals.

Therapeutic options for the treatment of multiple myeloma continue to evolve. Currently, high-dose melphalan followed…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next